FOXN3 possesses a unique forkhead box region that can interact with the promoter of the E2F5 transcription factor, inhibiting hepatocellular cancer cell proliferation by downregulating E2F5 mRNA and protein expression (14). Here, E2F5 is linked to hepatocellular carcinoma.